Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

7859.      Imbert-Laurenceau E, Crepinior J, Crance JM, Jouan A, Migonney V. Polystyrene derivatives substituted with arginine interact with Babanki (Togaviridae) and Kedougou (Flaviviridae) viruses. J Med Virol. 2003 Apr;69(4):503-9. 

7860.      Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol. 2003 May;70(1):91-8. 

7861.      Shu PY, Chang SF, Kuo YC, Yueh YY, Chien LJ, Sue CL, Lin TH, Huang JH. Development of group- and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J Clin Microbiol. 2003 Jun;41(6):2408-16. 

7862.      Vazquez S, Valdes O, Pupo M, Delgado I, Alvarez M, Pelegrino JL, Guzman MG. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. J Virol Methods. 2003 Jun 30;110(2):179-84.  

Pathogenesis

7863.      Blaney JE Jr, Manipon GG, Murphy BR, Whitehead SS.  Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice. Arch Virol. 2003 May;148(5):999-1006.

7864.      Cologna R, Rico-Hesse R.  American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol. 2003 Apr;77(7):3929-38.

7865.      Jones CT, Ma L, Burgner JW, Groesch TD, Post CB, Kuhn RJ.   Flavivirus capsid is a dimeric alpha-helical protein. J Virol. 2003 Jun;77(12):7143-9.

7866.      Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J.  Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol. 2003 May;70(1):91-8.

7867.      Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA.  DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med. 2003 Apr 7;197(7):823-9.

7868.      Wei HY, Jiang LF, Xue YH, Fang DY, Guo HY.  Secreted expression of dengue virus type 2 full-length envelope glycoprotein in Pichia pastoris. J Virol Methods. 2003 Apr;109(1):17-23.

Vaccines:

7869.      Konishi E, Terazawa A, Imoto J. Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice. Vaccine. 2003 May 16;21(17-18):1826-32. 

7870.      Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S, Sittisombut N, Malasit P. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods. 2003 Apr;109(1):55-61. 

Therapy:

7871.      Ostronoff M, Ostronoff F, Florencio R, Florencio M, Domingues MC, Calixto R, Sucupira A, Souto Maior AP, Matias C, Matias K, Tagliari C, Soussain C. Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin. Clin Infect Dis. 2003 Jun 15;36(12):1623-4.  

7872.  Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S, Sittisombut N, Malasit P. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods. 2003 Apr;109(1):55-61.